The world knows Martin Shkreli mostly for his controversial decision to crank up the price of an essential drug by 5,000 percent, earning him the moniker “Pharma Bro.” On Sunday, his Twitter account was suspended following a series of harassment Tweets directed at a female journalist.
The journalist in question is Lauren Duca and according to unnamed sources, she has been the subject of unwanted attention from Shkreli for several days, Boston Globe reports. The whole thing reportedly started after Duca’s appearance at a Fox News show hosted by Tucker Carlson where the two butted heads.
Before coming on, Duca had written a scathing article titled “Donald Trump is gaslighting America,” which was published in Teen Vogue. The Fox News host didn’t take kindly to how the president-elect was portrayed and made it known. After appearing on the show, Duca received numerous threats. Several days later, Shkreli started Tweeting the journalist with suggestive comments.
In one post, Shkreli asked Duca to be his plus-one during Trump’s inauguration, to which she responded by Tweeting “I would rather eat my own organs.” The pharmaceutical executive followed that up by posting photoshopped images of him and Duca, which the latter found inappropriate.
As a result of his actions, Twitter decided that it would be better for Shkreli to take some time off the micro-blogging service, confirming his suspension to the media via email. After the suspension, Duca made her own Tweet, wondering at how women immediately get harassed the moment they start getting attention for their work, Reuters reports.
"Why is harassment an automatic career hazard for a woman receiving any amount of professional attention?" Duca’s Tweet reads.
Considering what Shkreli is known to have done, which led to his dismissal as head of Turing Pharmaceuticals, this news might seem benign in comparison. However, it is indicative of a habit by “Pharma Bro” to not care about what anyone thought of his actions.


Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Instagram Outage Disrupts Thousands of U.S. Users
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Palantir Stock Jumps After Strong Q4 Earnings Beat and Upbeat 2026 Revenue Forecast
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 



